Monitoring of calcineurin inhibitors by NFATregulated gene expression in de novo renal allograft recipients on cyclosporine A

Ähnliche Einträge

• New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients
  von: Sommerer, Claudia, et al.
  Veröffentlicht: (2010)
• The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial
  von: Sommerer, Claudia, et al.
  Veröffentlicht: (2014)
• Monitoring of gene expression in tacrolimus-treated de novo renal allograft recipients facilitates individualized immunosuppression: results of the IMAGEN study
  von: Sommerer, Claudia, et al.
  Veröffentlicht: (2021)
• Pharmacodynamic monitoring of calcineurin inhibitor therapy: is there a clinical benefit?
  von: Sommerer, Claudia, et al.
  Veröffentlicht: (2009)
• Pharmacodynamic monitoring of cyclosporine a in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies
  von: Sommerer, Claudia, et al.
  Veröffentlicht: (2006)